¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
12/7 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2019-12-03
Á¶È¸¼ö
278


¾È³çÇϼ¼¿ä. ö±ÕÀÔ´Ï´Ù.  

À̹øÁÖ Åä¿äÀÏ ¼¼¹Ì³ª¿¡¼­ ¹ßÇ¥ÇÒ ³í¹®Àº
EMBO journal¿¡ ¿ÃÇØ(2019) 7¿ù ¹ßÇ¥µÈ
"Proteasomal degradation within endocytic organelles mediates antigen cross-presentation." À̶ó´Â Á¦¸ñÀÇ ³í¹®ÀÔ´Ï´Ù. 
±×µ¿¾È cross-presentationÀº cytosolic pathway¿Í vaculoar pathway Å©°Ô µÎ°¡ÁöÀÇ pathway·Î Á¤¸®µÇ¾ú°í,
Major pathwayÀÎ cytosolic pathwayÀÇ °æ¿ì, ´Ù¾çÇÑ ÈÄ¼Ó ¿¬±¸µéÀÌ ¼öÇàµÈ ¹Ý¸é,
ÈÄÀÚÀÎ vaculoar pathwayÀÇ °æ¿ì, BMDC ȤÀº imflamatory DC¿¡¼­¸¸ °üÂûµÇ±âµµ ÇÏ¿´°í, ÀÌÈÄ¿¡ ¸¹Àº º¸°í°¡ ÀÌ·ç¾î ÁöÁö ¾Ê¾Ò½À´Ï´Ù.  

À̹ø ³í¹®Àº ´Ù¼Ò ¿¬±¸°¡ ºÎÁ·Çß´ø vacular pathway¿¡¼­, ±×µ¿¾È ¾Ë·ÁÁ®¿Ô´ø °Í°ú´Â ´Ù¸£°Ô, phagosome / endosome ³»ºÎÀÇ proteasome¿¡ ÀÇÇØ
vacular pathway¸¦ ÅëÇØ cross-presentationÀÌ ¹ß»ýÇÒ ¼ö ÀÖÀ½À» º¸¿©ÁÖ´Â ³í¹®ÀÔ´Ï´Ù. 

Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù. 
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
12/14 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ±è³ª·¡
¾È³çÇϼ¼¿ä ³ª·¡ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ¿¡ ¹ßÇ¥ÇÒ ³í¹®Àº 2016³â immunity¿¡ °ÔÀçµÈ "Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation" À̶ó´Â Á¦¸ñÀÇ ³í¹®ÀÔ´Ï´Ù. º» ³í¹®Àº IL-4 stimulation¿¡ ÀÇÇÑ macrophageÀÇ metabolic ..
ÀÌÀü±Û
11/30 ¹ßÇ¥ ³í¹® ÀÔ´Ï´Ù
/ ±¸¹ÎÁ¤
¾È³çÇϼ¼¿ä, ±¸¹ÎÁ¤ÀÔ´Ï´Ù. À̹øÁÖ Á¦°¡ ¹ßÇ¥ÇÒ ³í¹®Àº cell reports¿¡ 2017³â¿¡ ¹ßÇ¥µÈ ³í¹®À¸·Î, Thymus¿¡¼­ÀÇ °­ÇÑ TCRgd signaling¿¡ ÀÇÇØ IL-17À» »ý¼ºÇÏ´Â gdT cellÀÇ ¹ß´ÞÀÌ ÀúÇصȴٴ ³»¿ëÀ» ¼Ò°³ÇÏ°í ÀÖ½À´Ï´Ù. thymus¿¡¼­ÀÇ TCR signal°ú gdTcellÀÇ effector function¿¡ ´ëÇؼ­ Á» ´õ ÀÌÇØÇØ º¸°íÀÚ º» ..